These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. [From the cytogenetics to the cytogenomics of thyroid tumors]. Perissel B; Bernheim A; Couturier J; Fouilhoux G; Vago P Bull Cancer; 2002 Jun; 89(6):588-92. PubMed ID: 12135859 [TBL] [Abstract][Full Text] [Related]
27. Adenomas and follicular carcinomas of the thyroid display two major patterns of chromosomal changes. Castro P; Eknaes M; Teixeira MR; Danielsen HE; Soares P; Lothe RA; Sobrinho-Simões M J Pathol; 2005 Jul; 206(3):305-11. PubMed ID: 15852498 [TBL] [Abstract][Full Text] [Related]
28. Cyclooxygenase 1 and 2 expressions in the human thyroid gland. Lee HM; Baek SK; Kwon SY; Jung KY; Chae SW; Hwang SJ; Woo JS; Lee JY Eur Arch Otorhinolaryngol; 2006 Mar; 263(3):199-204. PubMed ID: 16362262 [TBL] [Abstract][Full Text] [Related]
29. Studies of allelic loss in thyroid tumors reveal major differences in chromosomal instability between papillary and follicular carcinomas. Ward LS; Brenta G; Medvedovic M; Fagin JA J Clin Endocrinol Metab; 1998 Feb; 83(2):525-30. PubMed ID: 9467569 [TBL] [Abstract][Full Text] [Related]
30. Phosphorylation and inactivation of Tob contributes to the progression of papillary carcinoma of the thyroid. Ito Y; Suzuki T; Yoshida H; Tomoda C; Uruno T; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Kuma K; Yamamoto T; Miyauchi A Cancer Lett; 2005 Apr; 220(2):237-42. PubMed ID: 15766599 [TBL] [Abstract][Full Text] [Related]
31. Metanephric adenoma lacks the gains of chromosomes 7 and 17 and loss of Y that are typical of papillary renal cell carcinoma and papillary adenoma. Brunelli M; Eble JN; Zhang S; Martignoni G; Cheng L Mod Pathol; 2003 Oct; 16(10):1060-3. PubMed ID: 14559991 [TBL] [Abstract][Full Text] [Related]
32. Molecular rearrangements in papillary thyroid carcinomas. Zitzelsberger H; Bauer V; Thomas G; Unger K Clin Chim Acta; 2010 Mar; 411(5-6):301-8. PubMed ID: 19958753 [TBL] [Abstract][Full Text] [Related]
33. Cytogenetic study of a nodular hyperplasia of the thyroid after irradiation for Hodgkin's disease. van den Berg E; van Doormaal JJ; Oosterhuis JW; de Jong B; Buist J; Vos AM; Dam A; Vermeij A Cancer Genet Cytogenet; 1991 May; 53(1):15-21. PubMed ID: 2036636 [TBL] [Abstract][Full Text] [Related]
34. Cytogenetic characterization of a new human papillary thyroid carcinoma permanent cell line (GLAG-66). Antonini P; Linares G; Gaillard N; Venuat AM; Schlumberger M; Travagli JP; Caillou B; Berger R; Parmentier C Cancer Genet Cytogenet; 1993 Jun; 67(2):117-22. PubMed ID: 8330267 [TBL] [Abstract][Full Text] [Related]
35. Deletion of part of the long arm of chromosome 13 as the only karyotypic aberration in a follicular thyroid adenoma. Belge G; Thode B; Bullerdiek J; Bartnitzke S Cancer Genet Cytogenet; 1991 Oct; 56(2):277-80. PubMed ID: 1756473 [TBL] [Abstract][Full Text] [Related]
37. Molecular testing for oncogenic gene mutations in thyroid lesions: a case-control validation study in 413 postsurgical specimens. Giordano TJ; Beaudenon-Huibregtse S; Shinde R; Langfield L; Vinco M; Laosinchai-Wolf W; Labourier E Hum Pathol; 2014 Jul; 45(7):1339-47. PubMed ID: 24830619 [TBL] [Abstract][Full Text] [Related]
38. Diagnostic value of CD56 immunohistochemistry in thyroid lesions. Pyo JS; Kim DH; Yang J Int J Biol Markers; 2018 May; 33(2):161-167. PubMed ID: 29799356 [TBL] [Abstract][Full Text] [Related]
39. Histology of familial thyroid tumours linked to a gene mapping to chromosome 19p13.2. Harach HR; Lesueur F; Amati P; Brown A; Canzian F; Kraimps JL; Levillain P; Menet E; Romeo G; Bonneau D J Pathol; 1999 Nov; 189(3):387-93. PubMed ID: 10547601 [TBL] [Abstract][Full Text] [Related]
40. Cytogenetic abnormalities in a patient with hypercalcemia and papillary thyroid carcinoma. Pathak S; Hsu TC; Samaan N; Hickey RC Hum Genet; 1982; 60(3):291-3. PubMed ID: 7106763 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]